The Immunogenetic Analysis of Acne Vulgaris
Science Journal of Clinical Medicine
Volume 2, Issue 2, March 2013, Pages: 58-63
Received: Apr. 15, 2013; Published: Apr. 2, 2013
Views 3030      Downloads 200
Authors
Anis Irawan Anwar, Dermatology and Venereology Department, Faculty of medicine Hasanuddin University, Makassar, Indonesia
Indropo Agusni, Dermatology and Venereology Department, Faculty of medicine Airlangga University, Surabaya, Indonesia
Muh. Nasrum Massi, Microbiology Department Faculty of medicine Hasanuddin University, Makassar, Indonesia; and Physiology
Irawan Yusuf, Department, Faculty of medicine Hasanuddin University, Makassar, Indonesia
Article Tools
PDF
Follow on us
Abstract
Polymorphisms that occur in the CYP1A1, CYP17 and TNF-α genes affects hyperkeratinzation process, se-bum production and inflammation in acne vulgaris. Polymorphisms of CYP1A1, CYP17 and TNF-α genes can be identified by using PCR and sequencing techniques. The aim of this study is to demonstrate the role of polymorphisms of CYP1A1, CYP17, and TNF-α genes and the interaction polimorphisms of CYP1A1, CYP17 and TNF-α genes to severe acne vulgaris. This study was conducted as an observational study with case-control method, in 64 patients with severe acne, and as controls 73 patients with mild acne and healthy people. Criteria based on Combined Acne Severity Classification. Biospesimen blood 1 ml taken from vena mediana cubiti then performed PCR and sequencing to determine the sequence of nucleotides in DNA fragments. The conclution from the study shows that polymorphisms of CYP1A1, CYP17, TNF-α genes and the interaction polimorphisms of CYP1A1, CYP 17 and TNF-α genes is not a risk factor for severe acne vulgaris, but polymorphism of CYP1A1 gene is a risk factor for acne vulgaris.
Keywords
Severe Acne Vulgaris, Polymorphisms of CYP1A1, CYP17, and TNF-α genes, Interactions polymorphisms of CYP1A1, CYP 17 and TNF-α genes
To cite this article
Anis Irawan Anwar, Indropo Agusni, Muh. Nasrum Massi, Irawan Yusuf, The Immunogenetic Analysis of Acne Vulgaris, Science Journal of Clinical Medicine. Vol. 2, No. 2, 2013, pp. 58-63. doi: 10.11648/j.sjcm.20130202.15
References
[1]
Efendi Z. Peranan kulit dalam mengatasi terjadinya akne vulgaris. USU Digital Library; 2003 [cited 2009 18 Apr]; [5 screens]. Available from: http://library.usu.ac.id/download/fk/histologi-zukesti3.pdf.
[2]
Gollnick H. Current concepts of the pathogenesis of acne. Drugs. 2003;63(15):1579-96.
[3]
Abdel-Hafez K, Mahran A, Hofny E, Mohammed K, Dar-weesh A, Aal A. The impact of acne vulgaris on the quality of life and psychologic status in patients from upper Egypt. Int J Dermatol. 2009;48:280-5.
[4]
James W, Berger T, Elston D. Andrew's diseases of the skin clinical dermatology. 10th ed. Philadelphia: Saunders Elsevier; 2006. 961 p.
[5]
Baumann M. Acne. In: Bauman L, Weisberg E, editors. Cosmetic dermatology principles and practice New York: The McGraw-Hill Companies; 2002. p. 55-61.
[6]
Leyden J. Topical treatment of acne vulgaris: retinoid and cutaneous irritation. J Am Acad Dermatol. 1998;38:S1-4.
[7]
Paraskevaidis A, Drakoulis N, Roots I, Orfanos C, Zouboulis C. Polymorphism in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology. 1998;196:171-5.
[8]
He L, Yang Z, Yu H, Cheng B, Tang W, Dong Y, et al. The relationship between CYP17-34T/C polymorphism and acne in Chinese subjects revealed by sequencing. Dermatology. 2006;212:338-42.
[9]
Baz K, Erdal M, Yazici A, Soymelez F, Guvenc U, Tasdelen B, et al. Association between tumor necrosis factor-alpha gene promoter polymorphism at -308 and acne in Turkish patients. Arch Dermatol Res. 2008;300:371-6.
[10]
Jugeau S, Tenaud I, Knol A, Jarrousse V, Quereux G, Khammari A, et al. Induction of toll-like receptors by Pro-pionibacterium acnes. Br J Dermatol. 2005;153(6):1105-13.
[11]
Baron J, Heise R, Blaner W, Neis M, Joussen S, Dreuw A, et al. Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005;125:143-53.
[12]
Harper J. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol. 2004;51(1):S36-8.
[13]
Kristensen V, Haraldsen E, Anderson K, Lonning P, Erikstein B, Karesen R, et al. CYP17 and breast cancer risk: the polymorphism in the 5* flanking area of the gene does not influence binding to Sp-1. Cancer Res. 1999;59:2825-8.
[14]
Tuzuner B, Ozturk T, Kisakesen H, Ilvan S, Zerrin C, Ozturk O, et al. CYP17 (T-34C) and CYP19 (Trp39Arg) poly-morphisms and their cooperative effects on breast cancer susceptibility. in vivo. 2010;24:71-4.
[15]
Leyden J, Shalita A, Hordinsky M, Swinyer L, Stanczyk F. Efficacy of a low dose oral contraceptive containing 20 mg of ethinyl estradiol and 100 mg of levonorgestrel for the treatment of moderate acne : a randomized, placebocontrolled trial. J Am Acad Dermatol. 2002;47:399-409.
[16]
Feigelson H, Coetzee G, Kolonel L, Ross R, Henderson B. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 1997;57(6):1063-5.
[17]
Haiman C, Hankinson S, Spiegelman D, Colditz G, Willett W, Speizer F, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res. 1999;59(5):1015-20.
[18]
Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. Br J Dermatol. 2000;143(2):399-404.
[19]
Tian L, Xie H, Yang T, Hu Y, Li J. Correlation between CYP17 gene polymorphisms and female postadolescent acne in Han population in Hunan Province. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(7):1590-6.
[20]
D'alfonso S, Richiardi P. A polymorphic variation in a puta-tive regulation box of the TNFA promoter region. Immuno-genetics. 1994;39:150-4.
[21]
Szabo K, Tax G, Teodorescu-Brinzeu D, Koreck A, Kemeny L. TNFa gene polymorphisms in the pathogenesis of acne vulgaris. Arch Dermatol Res. 2011;303:19-27.
[22]
Somi M, Najafi L, Noori B, Alizadeh A, Aghah M, Shavakhi A, et al. Tumor necrosis factor-alpha gene promoter poly-morphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol. 2006;25:14-5.
[23]
Azmy I, Balasubramanian S, Wilson A, Stephenson T, Cox A, Brown N, et al. Role of tumour necrosis factor gene po-lymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6(4):395-400.
[24]
Boin F, Zanardini R, Pioli R, Altamura C, Maes M, Genna-relli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 2001;6(1):79-82.
[25]
Cuenca J, Perez C, Aguirre A, Schiattino I, Aguillon J. Ge-netic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res. 2001;34:237-41.
[26]
Zouboulis C, Korge B, Akamatsu H, Xia L, Schiller S, Gollnick H, et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol. 1991;96:792-7.
[27]
Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revus J, et al. Physiopathology of acne vulgaris: recent data, new un-derstanding of the treatments. Eur J Dermatol. 2004;14:4-12.
[28]
Stewart M, Benoit A, Downing D, Strauss J. Suppression of sebum secretion with 13-cis-retinoic acid: effect on individual skin surface lipids and implications for their anatomic origin. J Invest Dermatol. 1984;82(1):74-8.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186